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Nuclear Magnetic Resonance allows the non-invasive detection and quantitation of
metabolites to be carried out in cells and tissues. This means that that metabolic changes
can be revealed without the need for sample processing and the destruction of the
biological matrix. The main limitation to the application of this method to biological
studies is its intrinsic low sensitivity. The introduction of hyperpolarization techniques and,
in particular, of dissolution-Dynamic Nuclear Polarization (d-DNP) and ParaHydrogen
Induced Polarization (PHIP) is a significant breakthrough for the field as the MR signals
of molecules and, most importantly, metabolites, can be increased by some orders of
magnitude. Hyperpolarized pyruvate is the metabolite that has been most widely used for
the investigation of metabolic alterations in cancer and other diseases. Although d-DNP is
currently the gold-standard hyperpolarization method, its high costs and intrinsically slow
hyperpolarization procedure are a hurdle to the application of this tool. However, PHIP is
cost effective and fast and hyperpolarized pyruvate can be obtained using the so-called
Side Arm Hydrogenation approach (PHIP-SAH). The potential toxicity of a solution of the
hyperpolarized metabolite that is obtained in this way is presented herein. HP pyruvate
has then been used for metabolic studies on different prostate cancer cells lines (DU145,
PC3, and LnCap). The results obtained using the HP metabolite have been compared
with those from conventional biochemical assays.
Keywords: nuclear magnetic resonance, pyruvate, hyperpolarization, para-hydrogen, metabolism
INTRODUCTION
NMR is a powerful and non-invasive tool for the investigation of cellular metabolism as it allows a
wide range of metabolites to be detected either in cell cultures or in samples obtained from tissues
resected from living systems.
The main drawback of magnetic resonance spectroscopy in biological specimens is the low
intensity of the MR signals. Thermal nuclear spin polarization P is typically in the order of
10−5-10−6 for conventional high-field NMR spectrometers. The signal from water protons is
predominant by far, while cell metabolites, whose concentration is about 10,000 times lower, can
only be observed in vivo with low spatial resolution and after long acquisition times. Moreover,
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the 1H-NMR spectra acquired in vivo or in tissues can only
provide information about the concentration of metabolites in
a steady-state.
The breakthrough in the field came with the introduction of
the d-DNP hyperpolarization method (1), which increased the
sensitivity of MR signals by some orders of magnitude, thus
allowing the visualization of metabolites to be performed in
cells and in vivo. More interestingly, the acquisition of time-
resolved spectra becomes possible, thus providing information
about the kinetics of metabolic transformations, in cell cultures
and in vivo (2, 3).
[1-13C]pyruvate is the substrate that has been used most
widely for the study of cellular metabolism and its alterations in
diseases such as cancer, heart failure and stroke (4–8). Pyruvate
plays a central role in cellular metabolism as it can be converted
into a number of metabolites, depending on cellular conditions.
In most normal tissues, pyruvate dehydrogenase catalyzes the
decarboxylation of the pyruvate that enters the TCA cycle.
Pyruvate can also be transaminated by alanine aminotransferase
or reduced to lactate by lactate dehydrogenase. The presence of
disease can alter metabolic fluxes through the different enzymes
and an increased glycolytic flux is often observed in tumors.
The use of hyperpolarized pyruvate has shown a marked up-
regulation in the exchange of the 13C hyperpolarized label,
mediated by the LDH enzyme, between pyruvate and lactate
in tumor cells (9). Hyperpolarized [1-13C]pyruvate is currently
under intense scrutiny as a potential probe with which to assess
the presence and grading of prostate cancer in humans (10).
Unfortunately, d-DNP is an inherently slow, technologically
demanding and extremely expensive technique, limiting the
application of this powerful tool to a few laboratories worldwide.
ParaHydrogen Induced Polarization (PHIP) allows
hyperpolarized substrates to be obtained in a few seconds and
with much lower costs than d-DNP (11). This hyperpolarization
method is based on the hydrogenation, catalyzed by metal
complexes, of an unsaturated precursor of the target molecule
(12–14). On this basis the number of PHIP-polarizable substrates
appears to be limited by the availability of the proper unsaturated
precursor and the concerns about the biological applications
of the obtained hyperpolarized products are related to the
presence of residual metal catalyst and other impurities that are
associated to the hydrogenation reaction. The PHIP- side-arm
hydrogenation (PHIP-SAH) approach (15) is a good step
ahead as it circumvented both issues and can provide aqueous
solutions of hyperpolarized pyruvate, or other metabolites
(16), that can be safely used for in-vivo and in-cells studies
(17, 18). Nevertheless, although the PHIP-SAH procedure
allows most of the toxic compounds to be removed (catalyst
and solvent), traces that may affect the viability and metabolism
of cells may still be present in the aqueous phase of the
final product.
This work thoroughly investigate the toxicity of aqueous
solutions of the HP metabolites by performing in-vitro
cytotoxicity analyses on prostate cancer cell lines.
HP [1-13C]pyruvate was found to be a sensitive tool for
investigation into the difference in the metabolic phenotype
of two highly aggressive and metastasizing human prostate




13C-labeled HP pyruvate was obtained using the PHIP-
SAH method (Figure 1). The hydrogenation catalyst ([1,4-
bis(diphenylphosphino)butane](1,5-cyclooctadiene) rhodium(I)
tetrafluoroborate, Sigma Aldrich, 1.38 µmol) was dissolved in
deuterated chloroform (CDCl3, 100 µl). The propargylic ester
of [1-13C]pyruvate (3 µl, 26.6 µmol) was added to this solution.
A 5mm NMR tube (equipped with a gas valve) was used as the
hydrogenation reactor and was pressurized with 2.1 bar of para-
enriched hydrogen (∼86% enriched), while the NMR tube was
kept in a liquid nitrogen bath.
The sample was kept frozen in liquid nitrogen (time intervals
from 0.5 to 7 h) until the start of the hyperpolarization
experiment. The hyperpolarization procedure consisted of the
following steps:
a) Parahydrogenation reaction: the NMR tube containing the
frozen reaction mixture was quickly heated, via immersion in
a hot water bath (at 353K for 7 s), and then shaken for 3 s;
b) Polarization transfer: the NMR tube was opened to release
the parahydrogen pressure and immediately placed in the
magnetic field shield, to which magnetic field cycling (MFC)
was applied (18).
c) Hydrolysis: a base solution (260 µl of NaOH 0.1M and
Sodium Ascorbate 50mM), pressurized using argon (2bar)
and heated at ∼353K, was injected into the organic solution
to hydrolyze the hyperpolarized allyl-ester. An acidic buffer
solution (100 µl HEPES 144mM, pH 5.4) was then added
FIGURE 1 | Scheme reporting the key steps of the PHIP-SAH procedure: (1)
hydrogenation using parahydrogen of propargyl-[1-13C] pyruvate; (2)
polarization transfer to the 13C carboxylate spin by means of magnetic field
cycle (MFC); (3) hydrolysis and phase transfer of the Sodium salt from the
organic to the water phase.
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to the aqueous phase to reach physiological pH (7.2 ± 0.2
was measured).
d) Phase separation: the aqueous solution of the HP product
(250 ul) was taken up into a syringe and diluted with 600
µl of distilled H2O before being transported to the NMR
spectrometer, where 230 ± 11 ul of this solution was quickly
added to the NMR tube containing the cell suspension.
The concentration and hyperpolarization of [1-13C]pyruvate was
measured at the end of each experiment by acquiring a 13C-NMR
spectrum of the thermally polarized product with the addition of
13C-urea as an internal reference. The pyruvate concentration in
the cell suspensions was found to be 5.0± 0.4 mM.
13C-NMR Experiment Set-Up
The 13C-NMR spectra were carried out using 5mm NMR tubes,
instead of the previously reported 10mm sample tubes (18). A
standard 5 mm-ODWilmad NMR tube was equipped with a cap
modified with a central hole (inner diameter 2mm) and a glass
tube (2mm OD, 1.75mm ID, 8mm L) was inserted into the cap.
A PTFE tube (1mm OD, 0.75mm ID, 750mm L) was placed
inside the glass capillary tube and kept in the axial position, a
few mm above the cells suspension. The quick injection of the
aqueous solution of the hyperpolarized substrate through the
PTFE injection line allowed the cell suspension to mix with the
HP pyruvate. The PTFE tube was removed immediately after the
addition of theHP-pyruvate in order to avoid B0 inhomogeneities
during the acquisition of the 13C-NMR spectra.
13C-NMR Experiments: Cells Preparations
The metabolic transformation of [1-13C]pyruvate,
hyperpolarized through the PHIP-SAH procedure, into [1-
13C]lactate, was assessed on the following specimens: (I) prostate
cancer cells suspended in their growth medium; (II) intact cells
suspended in lactate-enriched medium; (III) lysed cells. The
samples (volume of 300 ul) were placed in the 5mm NMR
tube equipped with the Teflon transfer line ready to receive the
addition of the HP substrate. The NMR tube was positioned into
the NMR spectrometer (600 MHz Bruker Avance) where it was
kept at 310 K.
The contents of the specimens were as follows:
I. Pyr/Lac tests in cells suspension: cells were harvested from
plates (2ml of warm 0.25% Trypsin 0.53mM EDTA solution),
counted using a Burker chamber and then centrifuged in
the growth medium for 5min at 125 × g-force. Once
the supernatant was removed, 9.2 ± 0.2M cells for each
experiment were found to be suspended in 300 µl of culture
medium and transferred into a 5mm NMR test tube.
II. Pyr/Lac test in cells suspension in the presence of added Lac:
the cell-containing sample was prepared as in I, L-lactate was
then added to the culture medium and left to equilibrate for
10min in the NMR spectrometer before the injection of the
HP-pyruvate. At the end of the experiment, after the addition
of the aqueous solution of the HP metabolite, the final lactate
concentration was 5.94± 0.14 mM.
III. Pyr/Lac test in the presence of Lysed cells: for each experiment,
the lysed cell solution was obtained by twice freeze-thawing
cell suspension in liquid nitrogen. The sample-containing cells
were prepared as in II. In this set of experiments L-lactate
(10mM) was also added to the growth medium and left to
equilibrate for 10min in the NMR spectrometer before the
HP experiment.
The acquisitions of the 13C-NMR spectra were carried out using a
small flip angle (18◦). A 2 s delay was applied between successive
acquisitions. The first acquisition started a few seconds before the
injection of the HP substrate.
The vitality of the cells at the end of the hyperpolarized
experiment was checked using the trypan blue exclusion test. The
viability in all of the experiments was 95%.
At the end of the experiment the number of cells was checked
via the quantification of Bradford proteins, using the specific
calibration line for each cell line.
The 13C NMR spectra were acquired on a Bruker Avance
14.1 T NMR spectrometer using a 5mm BBO probe equipped
with 1H and 13C coils.
Cells Cultures
The PC3, DU145, and LNCaP (prostate carcinoma) cell lines
were purchased from American Type Culture (ATCC R©). Cells
were kept for 72 h in 175 cm2 flasks at 310K in a humidified
atmosphere with 5% CO2 in the recommended culture media as
suggested by ATCC, in particular: LNCaP: RPMI1640 (D-glucose
25.0mM); PC3: F-12K (D-glucose 7.0mM); DU145: EMEM (D-
glucose 5.6mM). All the cells were used within the first 10
passages from unfreezing.
In-vitro Cytotoxicity
To assess the adverse effects of the aqueous PHIP-SAH
hyperpolarization derived solutions, the MTT test (based on
the enzymatic reduction of the tetrazolium salt MTT [3-(43-
dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromidein]) in
living, metabolically active cells was carried out on two prostate
cancer cell lines (DU145 and PC3).
For these tests, cells were harvested via trypsinization,
resuspended in fresh medium, and plated in the wells of 96-
well-microtiter plates at a volume of 0.1ml. Routinely 7,000–
16,000 cells, depending on the cell-lines growth curves, were
plated in each well. After 24 h, to ensure the cells adhesion,
the culture medium was removed, and replaced with a fresh
medium of the same composition as the one used in the
hyperpolarization procedure, i.e., 15% of the aqueous solution in
the final volume (0.1 ml).
At the end of the incubation period (1, 6, and 24 h), the
medium was replaced with 0.1ml of a 5 mg/ml solution of MTT
(purchased from Sigma, St. Louis, MO) in phosphate-buffered
saline (PBS 1X). After 4 h of incubation with MTT at 310K,
the supernatant was carefully sucked off and a solubilization
solution, 0.15ml of dimethyl sulfoxide, was added to dissolve the
insoluble purple formazan product into a colored solution and
the absorbance at 570 nm was read by a spectrophotometer.
Cells were plated in triplicate to minimize the variability
of the results. In each plate, 3 control wells for each cell line
were included.
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The PC3 and DU145 cells were treated with the
following solutions:
1. Aqueous solution of the product of the PHIP-SAH
procedure, prepared as described in the [1-13C]pyruvate
hyperpolarization paragraph (i.e., the aqueous phase resulting
after step c).
2. Aqueous solution obtained from the injection of the
pressurized and heated base through a chloroform solution of
the hydrogenation catalyst, without the addition of propargyl-
pyruvate. The solution is analogous to that in 1 but is expected
to contain only residues of chloroform and catalyst impurities.
3. Aqueous solution obtained from the injection of the
pressurized and heated base through chloroform, without the
hydrogenation catalyst. The aqueous solution is expected to
contain only traces of chloroform.
4. Aqueous solution of allyl-alcohol, at the same concentration
as that obtained from the hyperpolarization procedure.
5. Aqueous solution of the product of the PHIP-SAH procedure,
prepared with the addition of ethanol (5 ul) to the organic
phase. In this case the composition of the aqueous solution
is analogous to that in 1, but with an excess of ethanol. As this
composition was the one used in a previous in-vivo study (17),
its toxicity was tested in this work for completeness.
Lactate Dehydrogenase Assay
A commercial kit (Sigma-AldrichMAK066) was used to measure
the LDH activity in the cell lines. The kit was used according to
the manufacturer’s instructions. Briefly, 1 × 106 cells per sample
were rapidly homogenized by sonication (30% power, 21W, for
30 s) over ice in 500 µl of cold LDH Assay buffer, and was
then centrifuged at 10,000 g for 15min at 277K to remove the
insoluble material.
To ensure the readings were within the linear range of the
standard curve, 4–10 µl samples were added into duplicate wells
of a 96-well-plate, bringing the sample to the final volume of 50µl
with LDH Assay Buffer. After the addition of 50 µl of the Master
Reaction Mix the NADH production kinetics were measured via
the absorbance of the specific probe at 450 nm.
Extracellular Lactate Assessment
To determine the concentration of lactate in the supernatant,
cells were seeded on 75 mm2 plates. After overnight adhesion in
standard conditions (310K and 5% CO2), the culture medium
was replaced with a new one. After 72 h, the medium was
collected, and the cells were harvested by trypsinization and then
counted. The applied procedure allowed the amount of lactate
measured in the culture medium to be normalized to the number
of cells.
In order to immediately quench any possible residual
metabolism, one volume of culture medium was mixed with
two volumes of cold methanol in a vial, snap-frozen and left
2 h in liquid nitrogen. Proteins were then allowed to precipitate
at 250K for 30min and the sample was centrifuged at 16,000 g
at 277K for 20min. The supernatant was then collected and
immediately lyophilized to remove the methanol for subsequent
measurements, and was then reconstituted with 0.6ml of
phosphate buffer (0.15M K2HPO4, pH 7.0) in deuterated water
(D2O) for
1H NMR quantification.
The amount of extracellular lactate was determined using
NMR 1H spectrometry (see Supplementary Material).
Experiments were carried out in triplicate and the lactate
concentration in the samples (µmol/cell) was calculated based
on the internal standard reference. A known amount (0.35mM)
of 3-(trimethylsilyl)-propionic-d4 acid sodium salt (TSP-d4) was
added to act as a chemical shift reference for the calibration
of the NMR data (at 0.0 ppm) as well as an internal standard
for quantitation.
Intracellular Lactate Concentration
Methanol-chloroform-water extraction (M/C) was used to
extract metabolites from cells (19).
Briefly, cell pellets were promptly quenched in liquid nitrogen
followed by the addition of 0.5ml of cold methanol-chloroform
solution at a ratio of 2:1. After thawing over ice, samples were
vortexed for 60 s and sonicated. After 15min of contact with
the M/C solution, 0.25ml of chloroform and 0.25ml of distilled
water were added to the mixture to yield an emulsion, which was
vortexed and centrifuged at 13,000 g for 20min at 277K. The
upper layer which contained the water-soluble metabolites was
collected, lyophilized and reconstituted with 0.6ml of phosphate
buffer (0.15M K2HPO4, pH 7.0) in deuterated water (D2O) for
1H NMR quantification (see Supplementary Material).
An internal standard (TSP-d4) concentration of 0.03mM was




The cytotoxicity of the aqueous HP-pyruvate-containing
solutions obtained by PHIP-SAH (solution I) and of single
components was assessed. Cell viability was not affected by
solution I after 1 and 6 h of treatment while a toxicity effect was
observed after 24 h (Figure 2A). The solutions that contained
traces of chloroform plus catalyst (solution II) and chloroform
alone (solution III), showed a significant effect on the cell
viability after 6 h of treatment (Figures 2B,C). As their toxicity
appeared to be the same, one can draw the conclusion that
it is mainly associated with the presence of the chloroform
traces in the water phase. The hydrolysis side product allyl
alcohol (solution IV) did not show any significant effect on
the cell viability (Figure 2D). The presence of ethanol, the
hydrogenation co-solvent, in the water solution, had a toxicity
effect after 24 h treatment (Figure 2E).
LDH Activity
The conventional biochemical assay used for the measurement
of LDH activity showed that this enzyme was significantly more
active in PC3 than in DU145 cells (Figure 3A), while in the
LNCaP cells the activity of LDH was significantly lower than
in both the other. This latter finding is in agreement with the
fact that LNCaP cells are less glycolytic than the other two,
more aggressive prostate tumor models. It has already been
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FIGURE 2 | Results on the biocompatibility of the aqueous solutions obtained from the PHIP-SAH procedure. All cell lines were treated with: (A) an aqueous solution
of pyruvate obtained from the PHIP-SAH procedure; (B) an aqueous solution containing traces of chloroform and catalyst; (C) an aqueous solution containing
chloroform traces; (D) an aqueous solution of allyl alcohol and (E) the aqueous solution of the product of the PHIP-SAH procedure, to which ethanol was added. The
cells viability was assessed by MTT assay. Data are the mean +SD from three independent experiments (n = 3). *P ≤ 0.05, ***P ≤ 0.001, ns: not significant vs.
untreated control (100% viable); one-way ANOVA.
FIGURE 3 | (A) LDH activity in the three cell lines measured using a conventional biochemical assay on cells lysates; (B) amount of extracellular lactate obtained from
1H-NMR spectra of the growth medium; (C) amount of intracellular lactate measured by means of 1H-NMR of cells lysates; (D) rate of glucose consumption in PC3
and DU145 cells as obtained from the 1H-NMR spectra of the growth medium at three different timepoints. *P ≤ 0.01, ***P < 0.001; unpaired t-test.
shown that the metabolic phenotype of the LNCaP cells is
dramatically different from that of PC3 andDU145 cells (20). The
difference of LDH activity between PC3 and DU145 cells is also
significant, being PC3 cells much more glycolytic than DU145
cells. This difference has been further investigated by means of
the metabolomic measurements carried out in growth media and
cells extracts.
1H-NMR Metabolomic Measurements
From the 1H-NMR spectra of the culture medium it was
found that the production and accumulation of lactate in the
extracellular space is slower in the less aggressive cells (LNCaP).
If only the other two, more aggressive cell lines are considered,
the lactate production is faster in DU145 than in PC3 cells
(Figure 3B). Conversely, the intracellular lactate pool was larger
in PC3 than in DU145 cells (Figure 3C).
Measurements of the glucose content in the extracellular
medium, at different timepoints, showed that the rate of glucose
consumption was faster in DU145 than in PC3 cells (Figure 3D).
These results would appear to imply that glycolytic efficiency is
higher in PC3 than in DU145 cells.
13C-Hyperpolarization Experiments
When HP-[1-13C]pyruvate was added to the cells suspended in
their growth medium and then kept in the NMR spectrometer at
physiological temperature, lactate signal build-up was observed
immediately in the 13C-NMR spectra series. This was due to
the rapid exchange of the 13C hyperpolarized label between
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FIGURE 4 | (A) series of 13C-NMR spectra acquired after the perfusion of a cells suspension (PC3 cells, 10M) with the aqueous solution HP-[1-13C]pyruvate. Spectra
were acquired using small flip angle pulse (18◦) and 2 s delays between one scan and another. (B) expanded 13C-NMR spectrum at maximum intensity of the lactate
signal; (C) Time dependent pyruvate and lactate curves obtained from the integrals of the signals of the two metabolites in the 13C-NMR spectra reported in (A).
(D) time dependent lactate curves obtained after the addition of HP-pyruvate to a suspension of DU145, PC3, and LNCaP cells.
pyruvate and lactate that occurs in the intracellular compartment
(Figure 4). The lactate signal reached a maximum at about 20 s,
and then decayed due to the T1 relaxation processes. The
13C
signals that correspond to pyruvate and lactate were integrated
and the time-dependent signal intensities of lactate and pyruvate
were interpolated using a set of functions in order to obtain
information about the kinetics of the metabolic process. The
experimental results can be interpolated using a four-pool model
that takes into account intra- and extra-cellular pyruvate and
lactate, all mutually exchanging (21, 22). However, in the present
case, the spectral resolution did not allow us to discriminate
between the intra and extracellular metabolite signals, meaning
that the two-compartments model was used in order to avoid
errors that might be caused by over-parametrization (23).
The observed pyruvate and lactate peak intensities can be
fitted to a simple two-sites exchange model
Pyr ⇋ Lac
according to which, the 13C-NMR signals of [1-13C]pyruvate














where kPL and kLP are the kinetic constants of the pyruvateto-
lactate conversion and the T1 values are the decay time constants
of the 13C carbonyl sites. It has been shown that the model can
be further simplified by setting the back-conversion rate (kLP) to
zero (25). It follows that one deals with a two compartmentmodel
characterized by an unidirectional flow with the kinetic constant
kPL being an apparent overall pyruvate to lactate conversion
rate. The solutions of equations 1 and 2, given that Pyr(t = 0)
= [Pyr]∗Z, where [Pyr] is the concentration of hyperpolarized
pyruvate added to the test tube, Z is the enhancement factor, and
Lac(t = 0)= 0, are










































We must also be consider that the small flip angle pulses (ϕ)
that were used lead to further loss of polarization. In order to
take into account this factor, an envelope function exp(−λt) was
added to the observed signal intensity, where λ = l n(cosϕ)
1t and1t
is the time interval between successive pulses (26)
Pyr′=Pyr . exp (−λt) (5)
Lac′=Lac . exp (−λt) (6)
The kinetic constants obtained from the fittings were normalized
to the number of cells and the pyruvate-to-lactate conversion rate
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FIGURE 5 | Rate of pyruvate to lactate conversion obtained from the
experiments carried out using HP [1-13C]pyruvate on cells, in different
conditions: (A) intact cells (DU145, PC3 and LNCaP cells) cultured in their
proper culture medium, (B) intact cells suspended in the medium with added
lactate; (C) lysed cells and (D) cells cultured in the same medium (DMEM).
*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; unpaired t-test.









where v is the volume of the sample.
From the interpolation of the 13C-NMR time-dependent
signals LNCaP cells resulted to be less glycolytic than the other
two (PC3 and DU145), in agreement with the fact that LNCaP
cells have a more oxidative metabolic phenotype than the other
two (20), while DU145 were significantly more glycolytic than
PC3 cells (Figure 5A).
In the second set of experiments, lactate was added to the
medium in which cells were suspended, during the 13C-NMR
experiment, as reported by Day et al. (27). In this case, the
pyruvate-to-lactate conversion rate become significantly faster in
PC3 than in DU145 cells, while the apparent glycolytic efficiency
of the LNCaP cells was still significantly lower than in the other
two cell lines (Figure 5B).
The observed pyruvate-to-lactate exchange rate in intact
cells is the result of concomitant processes, namely the rate of
metabolite transport through the cellular membrane, and the
efficiency of the LDH enzyme. In order to get more information
about the differences in the metabolic phenotype of the two,
more aggressive cell lines (PC3 and DU145), another series
of experiments has been carried out on lysed cells. In these
experiments, the contribution of MCT1 mediated transport of
pyruvate to the extra to the intracellular compartment was
removed, while lactate was added to the medium in order to
mimic its intracellular concentration. In these experiments, the
exchange kinetics became higher in both cell lines (PC3 and
DU145) and were still slightly, even if not significantly, faster in
DU145 than in PC3 cells (Figure 5C).
It must also be noticed that the difference between PC3 and
DU145 cells was not significant when the cells were maintained
in the same growth medium (DMEM) (20) (Figure 5D), while
the growth rate of LNCap cells was exceedingly low.
DISCUSSION
One of the main concerns with the application of parahydrogen
hyperpolarized substrates in metabolic studies, both in cells and
in vivo, is the presence of toxic impurities in the aqueous solution
of the HP metabolite, traces of hydrogenation catalyst, organic
solvent, and reaction side-products. The cytotoxicity experiments
carried out in this work indicate that the aqueous solution of the
HP substrate has moderate toxicity when cells are incubated with
the product solution for 24 h. Interestingly, the toxicity appeared
to be mainly caused by traces of organic solvent (chloroform)
while the hydrolysis side-product allyl-alcohol did not affect cell
viability after 24 h of incubation. Most importantly, experiments
carried out using hyperpolarized substrates usually take place
in a timeframe of a few minutes after the perfusion of the
HP substrate. Therefore, on the basis of the herein reported
results, it can be reasonably assumed that cellular metabolism
is not affected by these chemicals during the time course of
the experiment.
In this work, the experimental set-up and procedure for
in-cell studies has been modified, compared to the previously
reported protocol (18). The improved system for the addition
of the hyperpolarized product through the cell suspension
allowed us to use small size NMR tubes (5mm NMR tubes)
instead of the previously reported 10mm NMR tubes. The
use of a smaller volume is a significant improvement as the
amount of cells necessary for each experiment was drastically
reduced, from 20 to 8–10M, and the spectral resolution was also
considerably increased.
When cellular metabolism was interrogated using HP-[1-
13C]pyruvate in intact cells, the pyruvate to lactate conversion
rate was slower in LNCaP than in the other two cell lines.
This is in agreement with the fact that the metabolic phenotype
of LNCaP is significantly different from that of the other two
cell lines and is also coherent with the lower LDH activity
measured using the conventional biochemical assay. Differently,
the pyruvate to lactate conversion rate of PC3 and DU145 cells,
measured using hyperpolarized pyruvate, was contradictory with
the LDH activity obtained from the biochemical assay applied to
both cell lines. In fact, while in the first set of experiments, DU145
appeared more glycolytic than PC3 cells (Figure 5A), the second
showed a higher LDH activity in the PC3 cells (Figure 3A).
In order to clarify this apparent contradiction, other series of
experiments using HP-[1-13C]pyruvate have been carried out on
intact cells suspended in their growth medium with added lactate
and on lysed PC3 and DU145 cells.
When lactate was added to the extracellular medium of the
intact cells, the apparent pyruvate-to-lactate exchange rate was
significantly increased in all the cell lines and in particular in the
PC3 cells. (Figure 5B).
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Conversely, in the experiments carried out on lysed cells, there
was not a significant difference between the 13C label exchange
kinetics of these two cell lines (Figure 5D).
In order to account for these experimental observations, two
different hypotheses can be put forward, one relying on the
oxidative lactate metabolism and the other based on the MCT4
mediated transport of lactate through the cellular membrane.
The first is based on the well-known fact that different
isoforms of LDH exist, that are tetramers of two kinds of subunits
(the M type and the H type), and have different affinity either
for pyruvate or for lactate. These subunits are encoded by two
similar genes (LDH-A and LDH-B, respectively). While LDH-A
supports the ability of malignant cells to convert pyruvate into
lactate, LDH-B is related to the oxidative use of lactate (28).
Therefore, the faster 13C label exchange between pyruvate and
lactate observed in the PC3 cells, after the addition of lactate
to the extracellular medium, might be due to higher LDH-B
expression, that leads to the more efficient oxidation of lactate
to pyruvate.
The biochemical assays seemed also to support this
hypothesis. In fact the biochemical LDH assay measured
the rate of lactate-to-pyruvate conversion, through the
spectrophotometric observation of NADH formation, and
the LDH activity was higher in PC3 than in DU145 cells. From
the glucose measurements carried out on the extracellular
medium it was also evident that glucose consumption and
lactate production was more efficient in DU145 cells, which
accumulate lactate in the extracellular compartment. On the
other hand, PC3 cells showed smaller glycolytic efficiency and
a larger amount of lactate in the intracellular space, which may
imply a more efficient use of lactate rather than glucose as an
oxidative substrate.
All of these observations seemed to point toward the view
that the oxidation of lactate into pyruvate is more efficient in
PC3 cells, while the LDH enzyme works preferentially as a
pyruvate reductase in the DU145 cells. The oxidative lactate
metabolism, associated with MCT-1 facilitated lactate uptake,
is at the core of a metabolic adaptation of cancer cells called
metabolic symbiosis (28).
The other possible explanation takes into account the effect
of MCT-mediated transport on the pyruvate-to-lactate exchange
rate, that has previously been investigated using hyperpolarized
pyruvate in cells (25, 29, 30) and in vivo (31). MCT-1 has a
broader distribution and has been associated with the uptake
and efflux of pyruvate, L-lactate and others through the plasma
membrane, while MCT-4 are mostly associated with the export
of lactate in cells with high glycolytic rates (32, 33). The effect
of the overexpression of MCT-4 in cancer cells on the pyruvate-
to-lactate exchange rate observed using hyperpolarized pyruvate
had been investigated as well (23). A recent study on MCT4
carried out by Contreras-Baeza et al. (34) showed that MCT4
is a high-affinity lactate transporter with a somewhat lower
affinity for pyruvate. This property confers MCT-4 expressing
cells the ability to export lactate against high ambient lactate level,
thus maintaining their lactate producing role, while MCT1 cells
revert from lactate producers to consumers. A higher expression
of MCT4 in DU145 cells than in PC3 may also explain the
observation that the pyruvate-to-lactate exchange rate becomes
more marked in the former cell line when the concentration
of lactate in the extracellular medium is increased. It must also
be noticed that the addition of lactate to the medium, in the
experiments carried out on lysed cells (Figure 5D), did not lead
to any significant difference in the exchange rate.
Although a thorough investigation of the expression of the
different isoenzymes (LDHA and LDHB) and MCTs (MC1 ad
MCT4) in the two, more aggressive prostate cancer cell lines
(PC3 and DU145) would be needed, it can be concluded that
the experiments reported herein have shown that the polarization
obtained on [1-13C]pyruvate, as obtained using the PHIP-SAH
methodology is more than sufficient for investigation of the
differences in the metabolic phenotype of prostate cancer cells
characterized by different aggressiveness (LNCaP, PC3, and
DU145). These findings pave the way for a number of possible
NMR investigations of cellular metabolism that go well-beyond
the pyruvate/lactate transformation investigated in this work.
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